Axiom Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Axiom Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,173,807	Closed	-$33.4M	–	151
2025 Q1	$33.4M	Buy	+2,173,807	New	+$38.8M	0.32%	47
2016 Q3	–	Sell	-624,750	Closed	-$31.4M	–	160
2016 Q2	$31.4M	Sell	624,750 -551,009	-47%	-$29.3M	0.91%	42
2016 Q1	$62.9M	Sell	1,175,759 -382,479	-25%	-$22.4M	1.96%	16
2015 Q4	$102M	Sell	1,558,238 -376,969	-19%	-$23.3M	3.3%	5
2015 Q3	$109M	Buy	1,935,207 +443,614	+30%	+$28.8M	3.45%	6
2015 Q2	$88.2M	Sell	1,491,593 -55,345	-4%	-$3.41M	2.53%	11
2015 Q1	$96.4M	Buy	1,546,938 +882,205	+133%	+$51.3M	2.61%	8
2014 Q4	$38.2M	Buy	+664,733	New	+$37M	0.94%	47

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Ion Asset Management Herzliya, Israel $818M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.04B AUM 91.14% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return